UBS Reiterates Sell Rating on The Campbell's Company
UBS maintains its sell rating for CPB with a $17 price target.
Key Points
- UBS analyst Peter Grom reiterated a sell rating on The Campbell's Company (CPB) with a price target of $17 on June 9, 2026.
- The Campbell's Company, trading at $22.73, has a market cap of $6.8 billion and a P/E ratio of 11.18.
- Insiders like Dorrance Bennett Jr and others have been buying shares, while UBS and other analysts maintain cautious ratings.
On June 9, 2026, UBS analyst Peter Grom reiterated a sell rating for The Campbell's Company (NasdaqGS: CPB) with a price target of $17. This comes as shares of Campbell's trade at $22.73.
Other Institutional Activity in The Campbell's Company
BlackRock, Inc. reduced its holdings significantly, cutting 7,791,883 shares to a total of 17,112,705 shares valued at about $381.1 million. Invesco Ltd. increased its position by 3,776,768 shares, resulting in 13,496,177 shares worth approximately $300.6 million. Vanguard Capital Management LLC established a new stake, holding 13,160,519 shares valued at $293.1 million. Meanwhile, State Street Corp and Dimensional Fund Advisors LP added 1,473,614 and 1,933,814 shares, respectively, bringing their totals to 12,509,743 shares ($278.6 million) and 10,239,231 shares ($228 million).
The Campbell's Company Stock Snapshot
Shares of The Campbell's Company are trading around $22.73. The company has a market capitalization of $6.8 billion and a P/E ratio of 11.18. Its forward P/E is slightly higher at 11.49. The stock's beta is a low 0.01, indicating minimal volatility compared to the market. Over the past year, the stock has ranged from a low of $19.56 to a high of $34.17, with current 50-day and 200-day moving averages of $20.90 and $26.74, respectively.
Recent Earnings
For its latest reporting period, The Campbell's Company generated revenue of approximately $9.93 billion, though revenue growth was slightly negative at -4.4%. The company reported earnings per share of $2.04, with a net margin of 6.12% and a return on equity of 15.39%. The next earnings report is expected on June 8, 2026.
Dividend
The Campbell's Company offers an annual dividend rate of $1.56, yielding 6.84%. The dividend payout ratio stands at 76.47%.
Insider Buying and Selling at The Campbell's Company
Recent insider activity includes purchases by Dorrance Bennett Jr, who bought 300 shares on June 9, 2026, at an average price of $21.45. Other insiders, including Mary Alice Dorrance Jr, Marc Bradley Lautenbach, Maria Teresa Hilado, Howard Averill, and Kurt Schmidt, also acquired shares on March 30, 2026.
Analysts Set New Price Targets
On June 9, 2026, UBS maintained its sell rating with a $17 price target. RBC Capital also maintained a hold rating with a $21 target. B of A Securities reiterated a sell rating, targeting $18, while Barclays set a $19 target with a sell rating on June 8. Morgan Stanley held its position with a $21 target on June 5. The overall analyst consensus is a hold, with a mean price target of $21.44 among 18 analysts.
About The Campbell's Company
The Campbell's Company, headquartered in Camden, New Jersey, is a leading player in the consumer defensive sector, specifically within the packaged foods industry. The company, led by CEO Mick J. Beekhuizen, employs around 13,700 people. It operates through two main segments: Meals & Beverages and Snacks. Its products, including well-known brands like Campbell's soups, Swanson broths, and Pepperidge Farm snacks, are sold across various retail channels in the U.S. and internationally.
Bottom Line
UBS's reaffirmation of a sell rating on The Campbell's Company reflects cautious sentiment among analysts, despite the company's strong brand presence. Investors often track such ratings for insights into potential market moves, though it's essential to remember that these are backward-looking assessments. The Campbell's Company remains a significant player in the packaged foods sector, with a robust portfolio of products.
See Also
This instant news alert was generated by automated narrative technology and financial data from Trueearnings and public regulatory filings. It is for informational purposes only and is not financial advice.